Glaxo and SmithKline Beecham face drugs sell-off to seal pounds 100bn mega-merger

Glaxo Wellcome and SmithKline Beecham are expected to sell some of their best-selling drugs in order to avoid a full-scale regulatory inquiry into their proposed pounds 100bn mega-merger. Meanwhile unions are asking the Government to block the deal, which they fear could lead to the loss of 10,000 jobs in the UK. Nigel Cope, City Correspondent, reports.

Disposals are likely in two areas of therapeutic drugs where Glaxo and SmithKline dominate their markets. In anti-viral drugs, used to treat infections such as Herpes, Glaxo markets the highly successful Zovirax and Valtrex while SmithKline has Famvir.

In drugs used to combat nausea caused from chemotherapy, Glaxo and SmithKline dominate the market with Zofran and Kytril respectively. The two companies expect they will have to make disposals in these areas in order to satisfy the competition authorities that consumer choice would be protected and that a position of market dominance would not be used to raise prices.

There is a parallel with the Glaxo takeover of Wellcome in 1995, when both companies had migraine treatments in late stages of development. Glaxo sold its drug to Zeneca.

The deal will be scrutinised by the Federal Trade Commission in the US and the European Commission in the European Union. However, it is possible that the UK competition authorities could seek to gain a role in the inquiry process.

Though a merged Glaxo-Wellcome and SmithKline Beecham would be a UK company with its base in London, unions have reacted angrily to the prospect of widescale redundancies here. They fear up to 10,000 job cuts as part of a pounds 1bn cost-cutting programme and say it will reduce the country's pool of skilled scientists, hit competition and reduce consumer choice. Roger Lyons, the general secretary of the MSF, the manufacturing, science and finance union, said: "Our concern is that the only advantage of the deal is in cutting costs by shedding jobs." The union is calling for urgent meetings with Margaret Beckett, President of the Board of Trade, as well as MEPs and both companies.

The biggest threat to jobs is at the two groups' head offices and sales and marketing centres. Glaxo's head office is in Greenford while SmithKline employs almost 2,000 people in head office and sales functions at several offices in Brentford.

It is not clear whether the group's main research and development centres could be threatened. Glaxo opened a pounds 700m facility in Stevenage in 1995. SmithKline spent pounds 250m on a new site in Harlow, Essex, which opened last April.

Neither company would comment on possible research closures though SmithKline said: "The driving force behind this merger is that it would build a R&D function that would be second to none."

The combined research spending of the merged group would be pounds 2bn. SmithKline claims this would be double the spending of any other drugs company. Analysts estimate that the UK job loss figure could be closer to 2,000, mostly from head office and sales functions.

They were responding to the surprise announcement late on Friday that the two companies were in detailed discussions which could lead to a full scale merger. The deal would be the largest merger in corporate history and create the third-largest company in the world after General Electric of the US and Royal Dutch-Shell, the Anglo-Dutch Group. It will also be the world's largest pharmaceuticals company, leapfrogging Merck of the US.

The proposals also mean that SmithKline has dropped its plans to merger with American Home Products in a pounds 77bn deal that was only announced last week.

The terms of the deal have already been decided even though the two groups first made contact only eight days ago. Glaxo shareholders will hold 59.5 per cent of the group with SmithKline investors holding the remaining 40.5 per cent. Sir Richard Sykes, Glaxo's chairman, will be executive chairman of the combined group. Jan Leschly, chief executive of SmithKline, will be chief executive.

The merger will provide a fees bonanza for the investment banks. Lazards, which is advising Glaxo, and Morgan Stanley, which is representing SmithKline, could net fees of pounds 100m, according to some estimates.

Analysts say the merger is likely to prompt another wave off consolidation in the pharmaceuticals industry. Drug company shares are expected to soar today as traders try to spot the next bid or merger target.

Zeneca yesterday dismissed suggestions that it would be forced to seek alliances in order to combat the Glaxo-SmithKline behemoth. "The company has been very successful in developing a drug portfolio in the past few years and there is no reason why that should not continue," a spokesman said.

Zeneca has concentrated on two areas, cardio-vascular drugs and cancer treatments.

Hoechst, the German drugs group said the Glaxo merger would intensify international competition. "If the industry concentration process continues, then all industry participants will have to re-think their positioning," it said.

Start your day with The Independent, sign up for daily news emails
ebooks
ebooksAn introduction to the ground rules of British democracy
Latest stories from i100
Have you tried new the Independent Digital Edition apps?
Independent Dating
and  

By clicking 'Search' you
are agreeing to our
Terms of Use.

iJobs Job Widget
iJobs Money & Business

Recruitment Genius: Mortgage Advisor - OTE £95,000

£40000 - £95000 per annum: Recruitment Genius: This is an exciting opportunity...

SThree: Trainee Recruitment Consultant

competitive: SThree: Are you passionate about sales?Do you have a keen interes...

Recruitment Genius: Loan Adviser - OTE £30,000

£17000 - £30000 per annum: Recruitment Genius: This is an exciting opportunity...

Recruitment Genius: Sales Assistant / Buyer

£15000 - £17000 per annum: Recruitment Genius: This company offers a range of ...

Day In a Page

Isis in Syria: Influential tribal leaders hold secret talks with Western powers and Gulf states over possibility of mobilising against militants

Tribal gathering

Influential clans in Syria have held secret talks with Western powers and Gulf states over the possibility of mobilising against Isis. But they are determined not to be pitted against each other
Gaza, a year on from Operation Protective Edge: A growing population and a compromised and depleted aquifer leaves water in scarce supply for Palestinians

Gaza, a year on from Operation Protective Edge

A growing population and a compromised and depleted aquifer leaves water in scarce supply for Palestinians
Dozens of politicians, bureaucrats and businessmen linked to Indian bribery scandal die mysteriously

Illnesses, car crashes and suicides

Dozens of politicians, bureaucrats and businessmen linked to Indian bribery scandal die mysteriously
Srebrenica 20 years after the genocide: Why the survivors need closure

Bosnia's genocide, 20 years on

No-one is admitting where the bodies are buried - literally and metaphorically
How Comic-Con can make or break a movie: From Batman vs Superman to Star Wars: Episode VII

Power of the geek Gods

Each year at Comic-Con in San Diego, Hollywood bosses nervously present blockbusters to the hallowed crowd. It can make or break a movie
What do strawberries and cream have to do with tennis?

Perfect match

What do strawberries and cream have to do with tennis?
10 best trays

Get carried away with 10 best trays

Serve with ceremony on a tray chic carrier
Wimbledon 2015: Team Murray firing on all cylinders for SW19 title assault

Team Murray firing on all cylinders for title assault

Coaches Amélie Mauresmo and Jonas Bjorkman aiming to make Scot Wimbledon champion again
Wimbledon 2015: Nick Bollettieri - Vasek Pospisil must ignore tiredness and tell himself: I'm in the quarter-final, baby!

Nick Bollettieri's Wimbledon Files

Vasek Pospisil must ignore tiredness and tell himself: I'm in the quarter-final, baby!
Ashes 2015: Angus Fraser's top 10 moments from previous series'

Angus Fraser's top 10 Ashes moments

He played in five series against Australia and covered more as a newspaper correspondent. From Waugh to Warne and Hick to Headley, here are his highlights
Greece debt crisis: EU 'family' needs to forgive rather than punish an impoverished state

EU 'family' needs to forgive rather than punish an impoverished state

An outbreak of malaria in Greece four years ago helps us understand the crisis, says Robert Fisk
Gaza, a year on from Operation Protective Edge: The traumatised kibbutz on Israel's front line, still recovering from last summer's war with Hamas

Gaza, a year on from Operation Protective Edge

The traumatised kibbutz on Israel's front line, still recovering from last summer's war with Hamas
How to survive electrical storms: What are the chances of being hit by lightning?

Heavy weather

What are the chances of being hit by lightning?
World Bodypainting Festival 2015: Bizarre and brilliant photos celebrate 'the body as art'

World Bodypainting Festival 2015

Bizarre and brilliant photos celebrate 'the body as art'
alt-j: A private jet, a Mercury Prize and Latitude headliners

Don't call us nerds

Craig Mclean meets alt-j - the math-folk act who are flying high